Texas researchers develop COVID nasal vaccine
KXAN TV, July 29, 2022
The Austin television station reported researchers at UTMB developed a COVID-19 vaccine delivered through the nose. It can add extra protection against COVID-19 since it can “effectively” kill the virus where it enters the body— the respiratory tract. The vaccine can be delivered in a nasal spray. Researchers found the new vaccine is stable, but they need to do further animal and human trials. “These efforts are underway and crucial since more than 10 billion doses of vaccines are needed across the globe, particularly in middle- to low-income countries, where the affordability of the current vaccines is a big concern,” said Dr. Ashok Chopra, UTMB microbiologist and co-author of the study. World Pharma News reported this news as well, and i45now interviewed Dr. Chopra about this second-generation vaccine.